Deborah Minor

President & Founder

Deborah Minor, Ph.D., founded Drug Discovery Alliances, Inc. in 2001 and has assembled a first-class network of experts to offer the full continuum of services needed to support leading life science firms and biotech start-ups to support their drug discovery, development and commercialization projects. In addition to deep experience as a senior chemist, Deborah has

overseen hundreds of projects across the life sciences and biotech spectrum, bringing broad technical, business and management experience in pharmaceutical development, manufacturing, and commercial operations.

After earning a Ph.D. in Medicinal Chemistry from University of North Carolina, Chapel Hill, Deborah has worked as an organic chemist for Rhone Poulenc, Accelyrs and MDL, marketing molecular modeling technologies and databases including Beilstein and Crossfire to the pharmaceutical industry.

ABOUT DRUG DISCOVERY ALLIANCES

With hundreds of projects brokered to date, Drug Discovery Alliances brings unrivaled experience and connections to your project. Our team knows your business, understands your challenges and becomes your go-to problem solver.

Established in 2001, Drug Discovery Alliances, Inc., is a minority-owned, US-based pharmaceutical research and development consultation firm specializing in establishing alliances that facilitate pharmaceutical R&D. DDA provides a global sourcing solution spanning the entire research and development continuum through alliance partners including medicinal chemistry, in vivo studies, in vitro studies, process research, cGMP API manufacturing, RSM manufacturing, commercial manufacturing, formulation, crystallization R&D, drug product manufacturing, sourcing, generic API sourcing, GMP audits, CMC consulting, regulatory consulting, and assisting companies with licensing and fund raising activities.

Based in North Carolina, DDA is a certified HubZone small business partner and a woman-owned business, certified by the Women’s Business Enterprise National Council (WBENC). DDA’s minority status helps companies meet their DEI goals and optimize tax credits.